GnRH agonist acts as ovarian protection in chemotherapy induced gonadotoxicity: An experiment using a rat model

Kurume Medical Journal

Volumn 54, Issue 1-2, 2007, Pages 25-29

  Go, Matsuo ^a   Ushijima, Kimio ^a   Shinagawa, Atsuhiko ^b   Takahashi, Syun Ichi ^a   Fujiyoshi, Naoki ^a   Takemoto, Syuji ^a   Terada, Atsumu ^a   Fukui, Akimasa ^a   Kamura, Toshiharu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Shinagawa Hospital   (Japan)

Author keywords

Apoptosis; Chemotherapy related amenorrhea; GnRH agonist; Ovarian protection

Indexed keywords

CISPLATIN; GONADORELIN AGONIST; LEUPRORELIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CHEMOTHERAPY; CONTROLLED STUDY; DISEASE MODEL; DRUG MECHANISM; FEMALE; GONADOTOXICITY; NONHUMAN; OVARY; OVARY FOLLICLE CELL; RAT; TOXICITY; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; FEMALE; GONADOTROPIN-RELEASING HORMONE; MODELS, ANIMAL; OVARY; RATS; RATS, WISTAR;

EID: 41749103763     PISSN: 00235679     EISSN: 18812090     Source Type: Journal    
DOI: 10.2739/kurumemedj.54.25     Document Type: Article

References (20)

1. Koyama H, Wada T, Nishizawa Y, Iwanaga T, Aoki Y et al. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer 1977; 39:1403-1409.
2. Horning SJ, Hoppe RT, Kaplan HS, and Rosenberg SA. Female reproductive potential after treatment for Hodgkin's disease. N Eng J Med 1981; 304:1377-1382.
3. Byrne J, Fears TR, Gail H, Pee D, Connelly RR et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 1992; 166:788-793.
4. Ortin TT, Shoshlak CA, and Donaldson SS. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience. Int J Radiol Oncol Biol Phys 1990; 19:873-880.
5. Pedersen T, and Peters H. Proposal for a classification of oocyte and follicles in the mouse ovary. J Reprod Fertile 1968; 17:555-557.
6. Nicosia SV, Matus-Ridley M, and Meadows AT. Gonadal effects of cancer therapy in girls. Cancer 1985; 55:2346-2372.
7. Chapman RM, Sutcliffe SB, and Malpas JS. Cytotoxic-induced ovarian failure in women in Hodgkin's disease. JAMA 1979; 242:1877-1881.
8. Hortobagyi GN, Buzdar AU, Marcus CE, and Smith TL. Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M. D. Anderson Hospital and Tumor Institute. NCI Monogr 1986; 1:105-109.
9. Shinagawa A. Cisplatin induced ovarian toxicity in rats-An experimental analysis-. J Kurume Med Assoc 1998; 61:220-226. (in Japanese)
10. Siris ES, Leventhal BG, and Vaitukaitis JL. Effects of childhood leukemia and chemotherapy of puberty and reproductive function in girls. N Engl J Med 1976; 294:1143-1146.
11. Damewood MD, and Grochow LB. Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertile Sterile 1986; 45:443-450.
12. Ataya KM, McKenna JA, Weintraub AM, Clark MR, and Lemaire WJ. A Latinizing Hormone-releasing hormone agonist for the prevention of chemotherapy-induced ovarian follicular loss in rats. Cancer Research 1985; 45:3651-3656.
13. Waxman JH, Ahmed R, Smith D, Wrigley PF, Gregory W et al. Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol 1987; 19:159-162.
14. Blumenfeld Z, Avivi I, Linn S, Epelbaum R, Ben-Shahar M et al. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonodotropin-releasing hormone agonist in parallel to chemotherapy. Human Reprod 1996; 11:1620-1626.
15. Ataya K, and Moghissi K. Chemotherapy-induced premature ovarian failure: Machanisms and prevention. Steroids 1989; 54:607-626.
16. Billig MC, Furuta I, and Hsueh AJ. Gonadotropin-Releasing Hormone Directly Induces Apoptotic Cell Death in the Rat Ovary: Biochemical in Situ Detection of Deoxyribonucleic Acid Fragmentation in granulose cells. Endocrinology 1994; 134:245-252.
17. Wallace WHB, Shalet SM, Crowne EC, Morris-Jones PH, Gattamaneni HR et al. Gonadal dysfunction due to Cisplatin. Medical and Pediatric Oncology 1989; 17:409-413.
18. Maneschi F, Benedetti-Panichi G, Scambia G, Salerno G, Agostino D et al. Menstrual and Hormone Patterns in Women Treated with High-Dose Cisplatin and Bleomycin. Gynecol Oncol 1994; 54:345-348.
19. Shapiro CL, Manola J, and Leboff M. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol 2001; 19:3306-3311.
20. Recchika F, Saggio G, Amiconi G, Blasio AD, Candeloro G et al. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer 2006; 106:514-523.